47N:F CITIUS PHARMAC. DL -001

EUR 0.13 0.00 ( 0.00)%
Icon

CITIUS PHARMAC. DL -001 (47N:F) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | F
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

EUR 0.13

0.00 (0.00)%

EUR 0.03B

2.80K

N/A

N/A

Icon

47N:F

CITIUS PHARMAC. DL -001 (EUR)
COMMON STOCK | F
EUR 0.13
0.00 ( 0.00)%
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

EUR 0.03B

N/A

EUR 0.13

CITIUS PHARMAC. DL -001 (47N:F) Stock Forecast

N/A

Based on the CITIUS PHARMAC. DL -001 stock forecast from 0 analysts, the average analyst target price for CITIUS PHARMAC. DL -001 is not available over the next 12 months. CITIUS PHARMAC. DL -001’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of CITIUS PHARMAC. DL -001 is Slightly Bearish, which is based on 2 positive signals and 4 negative signals. At the last closing, CITIUS PHARMAC. DL -001’s stock price was EUR 0.13. CITIUS PHARMAC. DL -001’s stock price has changed by +0.00% over the past week, -68.12% over the past month and -99.28% over the last year.

No recent analyst target price found for CITIUS PHARMAC. DL -001
No recent average analyst rating found for CITIUS PHARMAC. DL -001

Company Overview CITIUS PHARMAC. DL -001

Citius Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of critical care products. Its LYMPHIR, an FDA approved product, is a targeted immunotherapy for an initial indication in the treatment of cutaneous T-cell lymphoma. Its la...Read More

https://citiuspharma.com

11 Commerce Drive, Cranford, NJ, United States, 07016

22

September

EUR

Germany

Adjusted Closing Price for CITIUS PHARMAC. DL -001 (47N:F)

Loading...

Unadjusted Closing Price for CITIUS PHARMAC. DL -001 (47N:F)

Loading...

Share Trading Volume for CITIUS PHARMAC. DL -001 Shares

Loading...

Compare Performance of CITIUS PHARMAC. DL -001 Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for 47N:F

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To CITIUS PHARMAC. DL -001 (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
CSJA:F
CSL LTD SPON.ADR 2 +0.50 (+0.60%) EUR84.96B 33.27 20.82

Frequently Asked Questions About CITIUS PHARMAC. DL -001 (47N:F) Stock

Stock Target Advisor's fundamental analysis for CITIUS PHARMAC. DL -001's stock is Slightly Bearish.

Unfortunately we do not have enough data on 47N:F's stock to indicate if its a good dividend stock.

Unfortunately we do not have enough data on 47N:F's stock to indicate what its average analyst target is.

Unfortunately we do not have enough data on 47N:F's stock to indicate if its overvalued.

The last closing price of 47N:F's stock was EUR 0.13.

The most recent market capitalization for 47N:F is EUR 0.03B.

Unfortunately we do not have enough analyst data on 47N:F's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains CITIUS PHARMAC. DL -001's stock.

As per our most recent records CITIUS PHARMAC. DL -001 has 22 Employees.

CITIUS PHARMAC. DL -001's registered address is 11 Commerce Drive, Cranford, NJ, United States, 07016. You can get more information about it from CITIUS PHARMAC. DL -001's website at https://citiuspharma.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Frequently Asked Questions About CITIUS PHARMAC. DL -001 (47N:F) Stock

Stock Target Advisor's fundamental analysis for CITIUS PHARMAC. DL -001's stock is Slightly Bearish.

Unfortunately we do not have enough data on 47N:F's stock to indicate if its a good dividend stock.

Unfortunately we do not have enough data on 47N:F's stock to indicate what its average analyst target is.

Unfortunately we do not have enough data on 47N:F's stock to indicate if its overvalued.

The last closing price of 47N:F's stock was EUR 0.13.

The most recent market capitalization for 47N:F is EUR 0.03B.

Unfortunately we do not have enough analyst data on 47N:F's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains CITIUS PHARMAC. DL -001's stock.

As per our most recent records CITIUS PHARMAC. DL -001 has 22 Employees.

CITIUS PHARMAC. DL -001's registered address is 11 Commerce Drive, Cranford, NJ, United States, 07016. You can get more information about it from CITIUS PHARMAC. DL -001's website at https://citiuspharma.com.
Loading...